AT343083B - Verfahren zur herstellung von granulaten - Google Patents

Verfahren zur herstellung von granulaten

Info

Publication number
AT343083B
AT343083B AT415075A AT415075A AT343083B AT 343083 B AT343083 B AT 343083B AT 415075 A AT415075 A AT 415075A AT 415075 A AT415075 A AT 415075A AT 343083 B AT343083 B AT 343083B
Authority
AT
Austria
Prior art keywords
granules
manufacturing
Prior art date
Application number
AT415075A
Other languages
English (en)
Other versions
ATA415075A (de
Original Assignee
Klinge Co Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Co Chem Pharm Fab filed Critical Klinge Co Chem Pharm Fab
Publication of ATA415075A publication Critical patent/ATA415075A/de
Application granted granted Critical
Publication of AT343083B publication Critical patent/AT343083B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT415075A 1974-06-04 1975-05-30 Verfahren zur herstellung von granulaten AT343083B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742426812 DE2426812A1 (de) 1974-06-04 1974-06-04 Verfahren zur herstellung von granulaten

Publications (2)

Publication Number Publication Date
ATA415075A ATA415075A (de) 1977-09-15
AT343083B true AT343083B (de) 1978-05-10

Family

ID=5917213

Family Applications (1)

Application Number Title Priority Date Filing Date
AT415075A AT343083B (de) 1974-06-04 1975-05-30 Verfahren zur herstellung von granulaten

Country Status (8)

Country Link
JP (1) JPS516869A (de)
AT (1) AT343083B (de)
BE (1) BE829449A (de)
DE (1) DE2426812A1 (de)
FR (1) FR2273584A1 (de)
GB (1) GB1513166A (de)
LU (1) LU72652A1 (de)
NL (1) NL7506615A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
GB2287880A (en) * 1994-03-14 1995-10-04 Euro Celtique Sa Production of sustained release compositions
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
US5700410A (en) * 1992-10-16 1997-12-23 Nippon Shinyaku Co., Ltd. Method of manufacturing wax matrices
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US7399488B2 (en) 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
CN110507658B (zh) * 2019-09-18 2022-10-21 国药集团致君（深圳）制药有限公司 头孢呋辛酯药物组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4856577A (de) * 1971-11-22 1973-08-08

Also Published As

Publication number Publication date
BE829449A (fr) 1975-09-15
GB1513166A (en) 1978-06-07
NL7506615A (nl) 1975-12-08
ATA415075A (de) 1977-09-15
FR2273584A1 (fr) 1976-01-02
LU72652A1 (de) 1975-10-08
DE2426812A1 (de) 1976-01-02
JPS516869A (ja) 1976-01-20

Similar Documents

Publication Publication Date Title
AT342794B (de) Verfahren zur herstellung von formteilen
AT338420B (de) Verfahren zur herstellung von adriamycinen
AT347130B (de) Verfahren zur herstellung von terpolymerisaten
AT343083B (de) Verfahren zur herstellung von granulaten
DD127731A5 (de) Verfahren zur herstellung von cephalosporansaeurederivaten
ATA966275A (de) Verfahren zur herstellung von p-benzochinondiketalen
AT346850B (de) Verfahren zur herstellung von epoxiden
AT333774B (de) Verfahren zur herstellung von 3-phenylpyridazonen
AT335989B (de) Verfahren zur kontinuierlichen herstellung von 2-athylhexanol
AT342307B (de) Verfahren zur herstellung von polyurethanen
AT344574B (de) Verfahren zur herstellung von formsteinen
DD122962A5 (de) Verfahren zur herstellung von halogenanthrachinonen
AT343120B (de) Verfahren zur herstellung von 6-chlor-2-chlormethyl-4-phenylchinazolin-3-oxid
AT341672B (de) Verfahren zur herstellung von 3-methylencephamsulfoxiden
AT334909B (de) Verfahren zur herstellung von substituierten thiocarbaminsaure-s-alkylestern
AT339268B (de) Verfahren zur herstellung von acetoxybutanolen
AT338747B (de) Verfahren zur herstellung von butandiolen
DD122986A1 (de) Verfahren zur herstellung von polyesteralkoholen
AT339925B (de) Verfahren zur herstellung von beta-chlorathyltrichlorsilan
AT344171B (de) Verfahren zur herstellung von indolyl-pyridyl-ketonen
AT335063B (de) Verfahren zur herstellung von d(-)-alfa-amino-p-hydroxybenzylpenicillin
AT339269B (de) Verfahren zur herstellung von propargylaminen
AT344675B (de) Verfahren zur herstellung von 3-fluor-dl-alanin
DD122973A5 (de) Verfahren zur herstellung von 4a-aryl-transdecahydroisochinolinen
ATA233075A (de) Verfahren zur herstellung von 16alpha- und 16beta-methal-9alpha-chlor- oder -flour-21- -desoxyprednisolonestern und -aethern